menu search

Pliant therapeutics to participate in upcoming investor events

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focus...

February 7, 2023, 1:01 pm

Should investors buy or sell the vaccinex patent news?

Shares of Vaccinex, Inc. (NASDAQ: VCNX) are charging higher on February 7 on news that the clinical-stage biotechnology company secured a patent. VCNX...

February 7, 2023, 11:10 am

Empower clinics partners with nuclear medicine specialist to launch us clinical trial management services

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said it has entered into a letter of intent (LOI) with Dr Bharat Mocherla, a Nuclear Medicine Specialist i...

February 7, 2023, 9:54 am

Why is rubius therapeutics (ruby) stock down 16% today?

Rubius Therapeutics (NASDAQ: RUBY ) stock is falling hard on Tuesday after the biotechnology company received a Nasdaq delisting notice. According to ...

February 7, 2023, 8:46 am

Why is vaccinex (vcnx) stock up 67% today?

Vaccinex (NASDAQ: VCNX ) stock is rocketing higher on Tuesday despite a lack of news from the clinical-stage biotechnology company. Instead, it looks ...

February 7, 2023, 7:41 am

Is biotech immunocore about to make a 25% price move?

The industry is home to some large-cap heavyweights, including Amgen Inc. (NASDAQ: AMGN), Gilead Sciences Inc. (NASDAQ: GILD), Regeneron Pharmaceutica...

February 7, 2023, 7:00 am

Verona pharma: small biotech targeting $10bn copd market with a late stage drug

Verona Pharma is a UK-based biotech with a $1.6Bn market cap developing a phase 3 asset targeting COPD....

February 7, 2023, 6:01 am

Arvinas to participate in upcoming investor conferences

NEW HAVEN, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drug...

February 6, 2023, 9:30 pm

Arvinas to participate in upcoming investor conferences

NEW HAVEN, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs...

February 6, 2023, 4:30 pm

Hillstream biopharma to host virtual r&d day to showcase its emerging immuno-oncology pipeline targeting drug-resistant cancers

Quatramer-based HSB-1216 combined with anti-MUC1-C antibody designed to target cancer stem cells (CSCs) by inducing ferroptosis in drug resistant canc...

February 6, 2023, 12:00 pm

Revive therapeutics secures supply of mdma from pharmaala biotech for transdermal patch development

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) said it has entered into a supply agreement with PharmaAla biot...

February 6, 2023, 8:40 am

Idorsia: interesting swiss biotech, but commercialization seems uncertain

Idorsia is a Swiss biopharmaceutical company with multiple commercial and pre-commercial assets. Idorisa's lead asset Daridorexant seems to be a more ...

February 4, 2023, 6:06 am

Senti biosciences announces new employment inducement grants

SOUTH SAN FRANCISCO, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a biotechnology company inno...

February 3, 2023, 9:05 pm

Jasper therapeutics, inc. reports inducement grant under nasdaq listing rule 5635(c)(4)

REDWOOD CITY, Calif., Feb. 03, 2023 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on d...

February 3, 2023, 9:05 pm

4 biotech stocks set to outpace q4 earnings estimates

Let us look at some biotech stocks, ALLO, EDIT, NTLA and SGEN that are poised to beat on fourth-quarter...

February 3, 2023, 3:48 pm

Ipo stock of the week: biotech leader immunocore approaches latest buy point

biotech leader Immunocore is just below its latest buy point ahead of quarterly earnings results. The p...

February 3, 2023, 2:58 pm

Alector: trading at cash despite late stage cns pipeline

Alector, Inc. has a lot of cash for a small biotech, but it is also trading at cash. Alector, Inc. has a late-stage program in a CNS indication and ma...

February 3, 2023, 2:13 pm

Why editas medicine's shares jumped this week

The gene-editing biotech's shares have had a strong two-week run....

February 3, 2023, 12:10 pm

Vyant bio commences a cash preservation plan including a reduction in force

Continuing to Explore Strategic Alternatives CHERRY HILL, N.J., Feb. 03, 2023 (GLOBE NEWSWIRE) — Vyant Bio, Inc. (“Vyant Bio” or “Company”) ...

February 3, 2023, 11:00 am

Regeneron stock rallies after profit and revenue beat expectations by wide margins

Shares of Regeneron Pharmaceuticals Inc. REGN, -0.90% rallied 1.9% toward a two-month high in premarket trading Friday, after the biotechnology compan...

February 3, 2023, 6:45 am


Search within

Pages Search Results: